Abstract
RATIONALE: Hyperekplexia is a rare hereditary neurological disorder characterized by an exaggerated startle response and generalized rigidity. It is frequently misdiagnosed as epilepsy, leading to unnecessary treatment. We report a case of mild hyperekplexia caused by a novel GLRA1 mutation, highlighting the diagnostic value of genetic testing in atypical presentations. PATIENT CONCERNS: An 18-month-old girl presented with recurrent episodes of vacant staring and limb rigidity triggered by sudden sounds or tactile stimuli over the past 2 months. She had a history of 3 febrile seizures but normal development. Physical examination revealed hypersensitivity to external stimuli, but the nose-tap test was negative. DIAGNOSES: Routine metabolic studies, brain magnetic resonance imaging, and electroencephalogram were normal. Whole-exome sequencing identified a de novo heterozygous nonsense variant c.593G > A (p.Trp198Ter) in the GLRA1 gene, confirming the diagnosis of hyperekplexia. INTERVENTIONS: Given the confirmed diagnosis and the mild nature of the symptoms, the previously prescribed antiepileptic drug (levetiracetam) was discontinued. Clonazepam was not initiated due to the mild severity of the condition. OUTCOMES: At the 8-month follow-up, the patient remained seizure-free with minimal non-epileptic stimulus-induced symptoms. Her growth and psychomotor development were normal. LESSONS: This case expands the phenotypic spectrum of GLRA1-related hyperekplexia to include mild phenotypes with a negative nose-tap test. It underscores the critical role of whole-exome sequencing in distinguishing hyperekplexia from epilepsy, thereby avoiding inappropriate antiepileptic therapy.